Donor Cells Implanted for Macular Degeneration

Researchers at the Riken Institute in Japan completed the first clinical trial involving the transplantation of induced pluripotent stem cells (iPS cells) from donors. Five patients received the donated cells. Artificially grown retinal cells were made from donor iPS cells and were used to treat the patients suffering from wet age-related macular degeneration. The first […]

Which medication is best for wet macular degeneration?

Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to patients who received no anti-VEGF treatments Researchers evaluated specific studies from databases and focused on 16 randomized controlled trials that had a total of 6347 […]

Revolutionary treatment restores vision

A study that involved a revolutionary treatment using stem cells from the eyes of non-living donors is detailed in STEM CELLS Translational Medicine. Researchers hope that this pioneering treatment may hold the key to finding a cure for blindness that is caused by damage to the cornea. Eight patients with condition known as Limbal stem […]

Gene therapy used to treat AMD

A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]

Oranges reduce AMD risk 60%

Forget an apple a day to keep the doctor away, reach for an orange as a recent study shows that eating an orange a day can reduce your risk of developing late macular degeneration by as much as 60 percent. The flavonoids found in oranges provide a special protection against age-related macular degeneration. Researchers at […]

Implantable Lucentis means fewer injections for wet macular degeneration

Fewer Injections for Wet Macular Degeneration? A tiny implantable device for the treatment of macular degeneration is in clinical trials and may be approved by the FDA. The device will lessen the burden of patients who currently must endure injections on a monthly basis to treat their wet form of macular degeneration. This breakthrough device […]

No More Eye Injections for Wet Macular Degeneration?

Genetech has formulated Lucentis’ active ingredient into a refillable eye implant that delivers the medication continuously into the eyes of wet macular degeneration patients. Known as the Port Delivery System, the implantable drug has shown promising results in the second phase of clinical studies. The Port Delivery System is slightly bigger than a grain of […]

Eat an orange a day to keep the AMD away

Oranges are the latest fruit to win accolades for their potential health benefits. The latest study was published in the American Journal of Clinical Nutrition. Researchers at the Westmead Institute for Medical Research were examining the effect flavonoids had on age-related macular degeneration (AMD). More than 2,000 Australian adults aged 50 and over were interviewed […]

Vision loss reversed with new stem cell therapy

A Phase 1 Clinical study of an experimental stem cell treatment for the web form of macular degeneration has resulted in two people having their vision loss reversed and their vision improving to being able to read with reading glasses. The study was published in Nature Biotechnology. Doctors used a surgical tool specifically designed for […]

Study compares Lucentis regimens for wet AMD

The treat-and-extend (TE) protocol of Lucentis (ranibizumab) is just as effective as a monthly regimen of ranibizumab when looking at increasing visual acuity in patients with neovascular age-related macular degeneration (AMD). The 12-month study was conducted in Portugal and led by Rufino Silvia, MD, PhD and involved 650 wet AMD patients aged 50 and older. […]